Hamilton Thorne Ltd (HTLZF) 0.0400 $HTLZF Hamilton

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hamilton Thorne Ltd (HTLZF) 0.0400 $HTLZF

Hamilton Thorne Announces Stock Option Grants
Marketwire Canada - Fri Mar 21, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has granted a total of 1,450,000 stock options to purchase common shares pursuant to the Company's incentive stock option plan. The options are exercisable at Cdn$0.05 per share, and expire ten years from the date of grant. A total of 1,100,000 of these options were granted to the Company's Directors, CEO, CTO and CFO. Grants to non-employee Directors vest over three years; grants to employees vest over four years.

Hamilton Thorne Announces Preliminary 2013 Financial Results
Marketwire - Thu Feb 13, 7:30AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2013.

Hamilton Thorne Announces 2013 Third Quarter Financial Results
Marketwire Canada - Wed Nov 27, 7:05AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine month period ended September 30, 2013.

Hamilton Thorne Launches New Dimensions II Strict Morphology Software for the IVOS II and CEROS II at ASRM 2013
Marketwire Canada - Mon Oct 14, 6:00PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company will be attending the American Society for Reproductive Medicine (ASRM) 69th Annual Meeting taking place in Boston, MA, October 13 - 17, 2013. ASRM is the premiere U.S. meeting on reproductive medicine and an ideal showcase for Hamilton Thorne to launch the Company's new DIMENSIONS(R) II Strict Morphology program for its CASA II systems, as well as showcase its new sperm imaging and analysis software introduced at the European Society for Human Reproduction and Embryology (ESHRE) meeting in London in July 2013. To learn more about Hamilton Thorne's full line of fertility products, including the new DIMENSIONS II and sperm imaging and analysis software, please visit the Company's booth # 323.

Hamilton Thorne Announces 2013 Second Quarter Financial Results
Marketwire Canada - Mon Aug 26, 3:05PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six months year-to-date ended June 30, 2013.

Hamilton Thorne Announces 2013 First Quarter Financial Results
Marketwire Canada - Tue May 28, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the first quarter ended March 31, 2013.

Hamilton Thorne Announces 2012 Fourth Quarter and Year-End Financial Results
Marketwire Canada - Mon Apr 29, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the fourth quarter and year-ended December 31, 2012.

Hamilton Thorne Announces Preliminary 2012 Fourth Quarter Financial Results
Marketwire Canada - Mon Feb 11, 3:30PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2012.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 757

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 293

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Bovespa Sinks Slightly as Market Adjusts; Key Movers Identified

Updated Category News Views 169

Overview of Market Movements in Brazil In the latest market update, stocks in Brazil saw a decline, marking a shift in investor sentiment. The Bovespa index, which is a significant indicator of market performance, dropped by 0.03%. Key sectors contributing to this decline included Financials, Electric Power, and Consumption, as a wave of selling pressure led shares lower....

Continue Reading
Unveiling Queens' Artistic Spirit at New JFK Terminal 6

Updated Category News Views 187

Embracing Art at JFK Terminal 6 Excitement is building for the new Terminal 6 at JFK International Airport, set to redefine traveling in New York with its innovative and community-oriented approach. This landmark terminal will showcase a rotating series of artworks from Queens-based artists, adding a vibrant cultural essence to the airport atmosphere. The 'Queens in...

Continue Reading
Market Outlook: BoE Rate Decision and Trade Dynamics

Updated Category News Views 128

Market Overview: Upcoming BoE Rate Decision As we look ahead to the coming week, all eyes are on the Bank of England's (BoE) impending decision regarding interest rates. This moment is poised to be a pivotal event in economic circles, as the central bank has the tough task of weighing inflation against growth in a market characterized by uncertainty. With inflationary...

Continue Reading
Stellantis Faces Profound Challenges Amid Dividend Concerns

Updated Category News Views 189

Stellantis (NASDAQ: STLA) saw its share price tumble over 4%, marking its lowest point since July 2022. This sharp decline didn’t just come out of nowhere; it was fueled by rising doubts surrounding the automaker's ability to sustain dividends after a concerning profit warning was issued earlier this week. Profit Warning Fallout: What Went Wrong? The profit warning has...

Continue Reading
Vistry Group Faces 30% Share Drop After Profit Guidance Cuts

Updated Category News Views 165

Vistry Group Shares Plummet Following Profit Guidance Revision Recently, Vistry Group Plc (LON: VTYV) experienced a significant decline in its share value, which dropped by 30% following a disappointing trading update. This announcement outlined a substantial reduction in profit expectations for the 2024 financial year due to unforeseen cost issues associated with their...

Continue Reading